Form 4 holding
Director
ALNYLAM PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 16,804
- Estimated value
- $7,561,800
- Report date
- 18 Aug 2025
- Price
- $450.00
- Ownership
- Direct
Michael W. Bonney - Director at ALNYLAM PHARMACEUTICALS, INC.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- ALNY on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Michael W. Bonney since 05 Sep 2025
Reported holdings for Michael W. Bonney in ALNYLAM PHARMACEUTICALS, INC.
Form 4 holding
Director
ALNYLAM PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 4,000
- Estimated value
- $1,263,000
- Report date
- 18 Aug 2025
- Price
- $315.75
- Ownership
- by Trust
Form 4 holding
Director
ALNYLAM PHARMACEUTICALS, INC.
- Security class
- Stock Option (right to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 18 Aug 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Michael W. Bonney in ALNYLAM PHARMACEUTICALS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.